Cargando…
The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline
The National Institutes of Health has partnered with the US Food and Drug Administration and the Defense Advanced Research Projects Agency to accelerate the development of human microphysiological systems (MPS) that address challenges faced in predictive toxicity assessment and efficacy analysis of...
Autores principales: | Sutherland, Margaret L, Fabre, Kristin M, Tagle, Danilo A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029183/ https://www.ncbi.nlm.nih.gov/pubmed/24565163 http://dx.doi.org/10.1186/scrt361 |
Ejemplares similares
-
Facilitating the commercialization and use of organ platforms generated by the microphysiological systems (Tissue Chip) program through public–private partnerships
por: Livingston, Christine A., et al.
Publicado: (2016) -
Meeting the unique challenges of drug discovery for neurodegenerative diseases
por: Shineman, Diana W, et al.
Publicado: (2009) -
The National Association of Specialty Pharmacy Abstract Program
por: Brook, Richard A., et al.
Publicado: (2019) -
Advancing inclusive science and systemic change: the convergence of national aims and institutional goals in implementing and assessing biomedical science training
por: Hurtado, Sylvia, et al.
Publicado: (2017) -
Focus on endocrine surgery
por: Conzo, Giovanni
Publicado: (2019)